Project Orbis Nears 30 Approvals In Oncology; Could China Be Added?

 
• By Ramsey Baghdadi
  
Confidentiality issues could be slowing US/China regulatory collaborations. • Source: Nielsen Hobbs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards